Atenolol
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Atenolol is a cardioselective beta-1 blocker used for hypertension and angina. It is hydrophilic and does not cross the blood-brain barrier readily, potentially causing fewer central nervous system side effects. However, it is no longer considered a first-line antihypertensive based on the LIFE trial showing inferiority to losartan for stroke prevention.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Atenolol is a cardioselective beta-1 blocker used for hypertension and angina. NutriStack rates the supporting evidence as moderate. Common adult dosing is 25–100 mg once daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete coq10. This profile indexes 10 sources.
- Effective blood pressure reduction
- Reduces angina frequency
- Fewer CNS side effects (hydrophilic)
- Once-daily dosing for most patients
- Bradycardia
- Fatigue
- Dizziness
- Severe sinus bradycardia
- Second- or third-degree heart block without pacemaker
The bottom line
Evidence rating moderate. Most-documented uses: effective blood pressure reduction, reduces angina frequency, fewer cns side effects (hydrophilic). 10 sources indexed (2013–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Selectively blocks beta-1 adrenergic receptors in the heart. Reduces heart rate, cardiac contractility, and cardiac output. Decreases renin secretion. Hydrophilic nature limits CNS penetration. Does not have intrinsic sympathomimetic activity or membrane-stabilizing properties.5
Dosing & protocol.
Can be taken with or without food; renally eliminated, requires dose adjustment in renal impairment
What it depletes.
Nutrients this medication can lower over time, and what to replace.
CoQ10
MildChronic beta-blocker therapy has been associated with lower tissue CoQ10 status and reduced mitochondrial electron transport support.
Full safety detail.
Side effects
- Bradycardia
- Fatigue
- Dizziness
- Cold extremities
- Nausea
- Depression (less common than lipophilic beta-blockers)
- Sexual dysfunction
Contraindications
- Severe sinus bradycardia
- Second- or third-degree heart block without pacemaker
- Cardiogenic shock
- Decompensated heart failure
- Sick sinus syndrome without pacemaker
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Systematic Review on the Efficacy of Atenolol in Antihypertensive Treatment: Recommendation from the Brazilian Society of CardiologyPMIDBrandão AA, Rodrigues CIS, Nadruz W et al. · Arquivos brasileiros de cardiologia · 2025
Brandão AA, Rodrigues CIS, Nadruz W et al.. Systematic Review on the Efficacy of Atenolol in Antihypertensive Treatment: Recommendation from the Brazilian Society of Cardiology. Arquivos brasileiros de cardiologia. 2025
- 2Does atenolol use during pregnancy cause small for gestational age neonates? A meta-analysisPMIDBratton S, Taylor MK, Cortez P et al. · Journal of perinatal medicine · 2024
Bratton S, Taylor MK, Cortez P et al.. Does atenolol use during pregnancy cause small for gestational age neonates? A meta-analysis. Journal of perinatal medicine. 2024
- 3Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic reviewPMIDWang Q, Xiang B, Chen S et al. · The Australasian journal of dermatology · 2019
Wang Q, Xiang B, Chen S et al.. Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review. The Australasian journal of dermatology. 2019
- 4Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysisPMIDKuyper LM, Khan NA · The Canadian journal of cardiology · 2014
Kuyper LM, Khan NA. Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis. The Canadian journal of cardiology. 2014
- 5Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)PMIDDiNicolantonio JJ, Lavie CJ, Fares H et al. · The American journal of cardiology · 2013
DiNicolantonio JJ, Lavie CJ, Fares H et al.. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). The American journal of cardiology. 2013
Reviews & position papers
1- 6Efficacy and safety of atenolol vs. propranolol for treatment of infantile haemangioma: a narrative reviewPMIDShi M, Wargon O, Tatian A · Clinical and experimental dermatology · 2025
Shi M, Wargon O, Tatian A. Efficacy and safety of atenolol vs. propranolol for treatment of infantile haemangioma: a narrative review. Clinical and experimental dermatology. 2025
Reference material
4- 7Dahlof B et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE). Lancet. 2002.Source linkedPMID
- 8Carlberg B et al. Atenolol in hypertension: is it a wise choice? Lancet. 2004.Source linkedPMID
- 9Hu J et al. A Systematic Review and Meta-Analysis of the Efficacy and Safety of Propranolol Versus Other Drugs in the Treatment of Infantile Hemangioma. J Cosmet Dermatol. 2026.Source linkedPMID
- 10Atenolol. 2006Source linkedPMID
Common questions.
Quick answers about Atenolol, drawn from the data on this page.
What is Atenolol?
Atenolol is a cardioselective beta-1 blocker used for hypertension and angina. It is hydrophilic and does not cross the blood-brain barrier readily, potentially causing fewer central nervous system side effects. However, it is no longer considered a first-line antihypertensive based on the LIFE trial showing inferiority to losartan for stroke prevention.
What is Atenolol used for?
Commonly cited benefits of Atenolol include: Effective blood pressure reduction; Reduces angina frequency; Fewer CNS side effects (hydrophilic); Once-daily dosing for most patients. NutriStack rates the overall evidence as moderate.
What is a typical dose of Atenolol?
A typical adult dose of Atenolol is 25–100 mg once daily (as prescribed by your physician). The commonly recommended form is Oral tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Atenolol?
Reported side effects include bradycardia, fatigue, dizziness, cold extremities, nausea, depression (less common than lipophilic beta-blockers). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Atenolol?
NutriStack rates this as Moderate, meaning several aligned RCTs or one large RCT plus supporting reviews. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Atenolol in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.